A PHASE I CLINICAL AND PHARMACOKINETIC STUDY OF BREQUINAR SODIUM, DUP-785 (NSC-368390), USING A WEEKLY AND A BIWEEKLY SCHEDULE

被引：27

作者：

BORK, E

VEST, S

HANSEN, HH

机构：

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 10期

关键词：

D O I：

10.1016/0277-5379(89)90097-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1403 / 1411

页数：9

共 15 条

[1] ARTEAGA C, 1988, P ASCO, V7
[2] CHEN SF, 1986, CANCER RES, V46, P5014
[3] COLLINS JM, 1986, CANCER TREAT REP, V70, P73
[4] DEFORNI M, 1987, 4TH P EUR C CLIN ONC
[5] DEXTER DL, 1985, CANCER RES, V45, P5563
[6] VARIABILITY OF INDIVIDUAL TOLERANCE TO METHOTREXATE IN CANCER PATIENTS
HANSEN, HH
SELAWRY, OS
HOLLAND, JF
MCCALL, CB
[J]. BRITISH JOURNAL OF CANCER, 1971, 25 (02) : 298 - &
[7] JOGGI J, 1988, P AACR, V29
[8] PETERS GJ, 1987, INVEST NEW DRUG, V5, P235
[9] ROED H, UNPUB EUR J CANCER C
[10] ROZENCWEIG M, 1985, European Journal of Cancer and Clinical Oncology, V21, P1005